Mankind Pharma buys Bharat Serum and Vaccines for $1.6 billion
India’s Mankind Pharma will buy Mumbai-based Bharat Serums and Vaccines for 136 billion rupees ($1.63 billion), according to a company statement.
Drugs
Health
Pharma
Drugs
Health
Pharma
16 Gaza Strip residents, mostly children, reach Spain for treatment
A woman and 15 other children from Gaza, who were undergoing medical care in Egypt for the last several months, have been evacuated.
Drugs
Health
Pharma
Pfizer’s haemophilia A gene therapy cuts bleeding rates during trials
HQ Team July 25, 2024: Pfizer’s haemophilia A gene therapy has reduced bleeding rates in patients during an end-stage trial, according to a.
Drugs
Health
Pharma
Biogen, Sage halt tremor trial after ‘disappointing’ oral drug results
An oral investigational drug jointly developed by Biogen Inc., and Sage Therapeutics Inc., failed to stop essential tremors in patients, forcing the companies.
Drugs
Health
Pharma
PrEPVacc HIV trials’ results ‘surprising’ as dummy group clocks less infections
HIV vaccine trials conducted in Eastern and Southern Africa threw up surprising results when more infections were reported in the two vaccine groups.
Drugs
Health
Pharma
Merck’s experimental RSV injection lowers infections in infants
The US-based Merck and Co.’s investigational medicine to protect infants from respiratory syncytial virus (RSV) disease has resulted in lowering infections, according to.
Drugs
Health
Pharma
Novo Nordisk’s Wegovy gets UK regulator nod to treat heart risks
The UK’s Medicines and Healthcare products Regulatory Agency has approved Novo Nordisk’s weight-loss drug to cut the risk of obesity and adults suffering.
Drugs
Health
Pharma
Poliovirus type 2 detected in sewage samples in war-torn Gaza: WHO
The World Health Organization’s laboratory network has detected six variants of poliovirus type 2 (cVDPV2) in sewage samples in war-torn Gaza and warned.
Drugs
Health
Pharma
Fund crunch, anti-rights push, slowing global target to end AIDS, UN says
A person dies every minute due to AIDS-related causes, and the world is off-track to achieve its goals with a quarter of 39.9.
Drugs
Health
Pharma
US-based Agilent Technologies to acquire Canada’s Biovectra for $925m
HQ Team July 23, 2024: Agilent Technologies Inc., will acquire Canada-based Biovectra, a contract development and manufacturing company, for $925 million, according to.